title: Maximizing the clinical benefit of novel therapies in multiple myeloma.
authors.affiliation: Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
authors.forename: Jacob
authors.initials: J
authors.lastname: Laubach
authors.forename: Constantine
authors.initials: C
authors.lastname: Mitsiades
authors.forename: Kenneth
authors.initials: K
authors.lastname: Anderson
authors.forename: Paul
authors.initials: P
authors.lastname: Richardson
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D009101:Multiple Myeloma / Q000628:therapy*; D033581:Stem Cell Transplantation